PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ibuprofen - Pain & inflammation - musculoskeletal
PAD Profile : Ibuprofen - Pain & inflammation - musculoskeletal
Keywords :
PNMP, NSAID, osteoarthritis, rheumatic disease, musculoskeletal pain
Brand Names Include :
Nurofen, Brufen
Traffic Light Status
Status 1 of 4.
Status :
Green
Preferred
Formulations :
- Oral suspension
- Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 4.
Status :
Green (see narrative)
Important
Formulations :
- Oro-dispersible
Important Information :
Reserved for patients with swallowing difficulties
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 4.
Status :
Non Formulary
Formulations :
- Capsules
- Modified release capsules
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 4 of 4.
Guidelines
No guidelines returned.
Other Drugs
- Celecoxib
- Diclofenac sodium
- Diclofenac sodium
- Naproxen
- Etoricoxib
- Naproxen
- Meloxicam
- Aceclofenac
- Diclofenac potassium
- Indometacin
- Nabumetone
- Etodolac
- Ketoprofen
- Mefenamic acid
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
07 August 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
A stepped approach to pain management is recommended. Paracetamol is considered a 1st line option for the treatment of pain. Consider initiation of an oral NSAID as an adjunct to paracetamol if required. See the guidelines attached for further information.
PLEASE NOTE: Oro-dispersible tablets should only be used when a patient has swallowing difficulties.
Associated BNF Codes
10. Musculoskeletal and Joint Diseases
10.01.01. Non-steroidal anti-inflammatory drugs